Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

BioCorRx (BICX) Gross Profit (2016 - 2025)

Historic Gross Profit for BioCorRx (BICX) over the last 15 years, with Q1 2025 value amounting to $134899.0.

  • BioCorRx's Gross Profit rose 680727.09% to $134899.0 in Q1 2025 from the same period last year, while for Mar 2025 it was $138944.0, marking a year-over-year increase of 49476.91%. This contributed to the annual value of $5998.0 for FY2024, which is 8872.01% down from last year.
  • BioCorRx's Gross Profit amounted to $134899.0 in Q1 2025, which was up 680727.09% from $4045.0 recorded in Q2 2024.
  • In the past 5 years, BioCorRx's Gross Profit ranged from a high of $134899.0 in Q1 2025 and a low of $1953.0 during Q1 2024
  • In the last 5 years, BioCorRx's Gross Profit had a median value of $11182.0 in 2021 and averaged $29001.6.
  • Its Gross Profit has fluctuated over the past 5 years, first crashed by 9385.19% in 2024, then soared by 680727.09% in 2025.
  • BioCorRx's Gross Profit (Quarter) stood at $11182.0 in 2021, then soared by 563.6% to $74204.0 in 2022, then tumbled by 92.07% to $5885.0 in 2023, then tumbled by 31.27% to $4045.0 in 2024, then skyrocketed by 3234.96% to $134899.0 in 2025.
  • Its Gross Profit was $134899.0 in Q1 2025, compared to $4045.0 in Q2 2024 and $1953.0 in Q1 2024.